Evidence map›Paper›PMID 24075347›Full record

ArticleAsian Pacific journal of tropical biomedicine2013

In vitro treatments of Echinococcus granulosus with fungal chitosan, as a novel biomolecule.

Bahman Rahimi-Esboei, Mahdi Fakhar, Aroona Chabra, Mahboobeh Hosseini

Open access · bronzeAbstract read
In one paragraph

Article in Asian Pacific journal of tropical biomedicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Scolicidal agents for protoscolices ofJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2017
    Review
  6. The anti-giardial effectiveness of fungal and commercial chitosan against Giardia intestinalis cysts in vitro.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2016
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Bahman Rahimi-EsboeiDepartment of Parasitology, School of Public health, Tehran University of Medical Sciences, Iran.
Mahdi Fakhar
Aroona Chabra
Mahboobeh Hosseini
Mazandaran University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determined the antiparasitic activity of the isolated chitosan from Penicillium viridicatum, Penicillium aurantiogriseum and commercial chitosan against protoscolicidal of hydatid cysts were determined.

methodsAfter isolating chitosan from fungal cell walls, four concentrations (50, 100, 200, 400 μg/mL) of each type of prepared chitosan and commercial chitosan were used for 10, 30, 60, and 180 min, respectively.

resultsAmong different type of chitosan, commercial chitosan with the highest degree of deacetylation showed high scolicidal activity in vitro. Fungal chitosan could be recommended, as good as commercial chitosan, for hydatic cysts control.

conclusionsIt seems to be a good alternative to synthetic and chemical scolicidal.

Indexed as

AnimalsAnthelminticsChitosanDose-Response Relationship, DrugEchinococcosisEchinococcus granulosusFungiSheepSheep DiseasesAnthelminticsChitosanChitosanEchinococcus granulosusPenicilliumProtoccoleces

Identifiers

PMID24075347
PMCPMC3761141
OpenAlexW2132684527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.